MIM
GSK icon

Macroview Investment Management’s GSK GSK Stock Holding History

Macroview Investment Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-168
Closed -$10K – 236
2013
Q2 		$10K Buy
+168
New +$10.7K 0.01% 80

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Macroview Investment Management's GSK Position: Q3 2013 in Review

Macroview Investment Management sold out of GSK (GSK) in Q3 2013, closing a stake of 168 shares — an estimated $10K sold.

Macroview Investment Management first reported a position in GSK in Q2 2013 and held it in 1 quarter. The position peaked at $10K in Q2 2013. 635 funds tracked by Wall St. Rank hold GSK as of Q3 2013.

  • Macroview Investment Management reported no remaining GSK position as of Q3 2013 after selling out during the quarter.
  • Macroview Investment Management sold 168 GSK shares in Q3 2013, an estimated $10K.
  • Macroview Investment Management first reported a position in GSK in Q2 2013 and held it in 1 quarter.
  • Macroview Investment Management's GSK position peaked at $10K in Q2 2013.
  • 635 funds tracked by Wall St. Rank held GSK as of Q3 2013.

Based on Macroview Investment Management's 13F filing for Q3 2013, filed 31 Oct 2013.